Health · 46 views
RNA therapy for genetic heart failure moves closer to patients after lab gains
Using patient-derived cardiac tissue and stem cell-based models, the team of translational researchers demonstrated that targeting the genetic cause of disease improved cellular abnormalities and identified the biological pathways involved.
Summary
Using patient-derived cardiac tissue and stem cell-based models, the team of translational researchers demonstrated that targeting the genetic cause of disease improved cellular abnormalities and identified the biological pathways involved. The results of this study were published in Signal Transduction and Targeted Therapy.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- Perimenopause is everywhere. How do you know if you’re in it? – podcastContinue reading
- Exploring the potential of immunotherapy in early-stage triple-negative breast cancerContinue reading
- Hemoglobin component heme shown to inhibit enzyme that helps dissolve blood clotsContinue reading
- How dismissed symptoms can push patients to breaking pointContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow